Skip to main content
    I

    InspireMD Inc (NSPR)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.60
    -0.04 (-6.85%)

    Market Cap: $30.13M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    InspireMD Inc (NSPR) Financials: Revenue, Profit and Cash Flow

    Updated Nov 12, 2026. Financial statements from company filings, amounts in US dollars.

    InspireMD reported revenue of $8.98M for the fiscal year ended Dec 31, 2025, up 28.1% from the year before. That year, net income was -$48.79M with a net margin of -543.3%, operating cash flow was -$35.10M and free cash flow was -$36.77M. The quarter ended Sep 30, 2026 had revenue of $2.24M and net income of -$9.76M.

    Revenue and Margins

    Over the 9 years to Dec 2025, revenue grew from $1.89M, a compound annual rate of 18.9%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$8.98M+28.1%29.5%-547.0%-543.3%
    Dec 2024$7.01M+13.0%21.5%-478.0%-456.6%
    Dec 2023$6.21M+20.0%29.1%-340.7%-321.0%
    Dec 2022$5.17M+15.0%21.6%-361.9%-357.6%
    Dec 2021$4.50M+80.9%16.8%-327.4%-331.9%
    Dec 2020$2.48M-33.2%3.3%-417.7%-424.3%
    Dec 2019$3.72M+3.3%20.3%-263.8%-269.8%
    Dec 2018$3.60M+30.4%27.6%-211.4%-201.1%
    Dec 2017$2.76M+45.8%21.2%-298.2%-305.6%
    Dec 2016$1.89MN/A5.4%-403.8%-446.7%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$8.98M$7.01M$6.21M$5.17M$4.50M$2.48M$3.72M$3.60M$2.76M$1.89M
    Cost of revenue$6.33M$5.50M$4.40M$4.05M$3.74M$2.40M$2.96M$2.61M$2.18M$1.79M
    Gross profit$2.65M$1.51M$1.81M$1.12M$754.00K$83.00K$756.00K$995.00K$585.00K$102.00K
    Research and development$15.00M$13.63M$7.98M$7.81M$5.16M$2.23M$2.95M$1.53M$1.28M$1.29M
    Operating income-$49.11M-$33.50M-$21.14M-$18.71M-$14.72M-$10.38M-$9.82M-$7.61M-$8.23M-$7.65M
    Net income-$48.79M-$32.01M-$19.92M-$18.49M-$14.92M-$10.54M-$10.04M-$7.24M-$8.44M-$8.46M
    EBITDA-$48.25M-$31.67M-$19.62M-$18.52M-$14.55M-$10.23M-$9.66M-$7.46M-$8.05M-$7.46M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$2.24M$1.77M$3.40M$3.15M$2.52M$1.78M$1.53M$1.95M$1.81M$1.74M$1.51M$1.76M
    Gross profit$240.00K-$774.00K$687.00K$1.18M$864.00K$313.00K$292.00K$469.00K$414.00K$331.00K$292.00K$505.00K
    Operating income-$9.95M-$14.45M-$13.98M-$12.08M-$13.05M-$13.02M-$11.46M-$9.37M-$8.46M-$8.26M-$7.41M-$5.81M
    Net income-$9.76M-$14.32M$289.00K-$11.76M-$12.71M-$13.15M-$11.17M-$9.17M-$7.89M-$7.91M-$7.03M-$5.41M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $1.07M by $7.87M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$69.40M$46.81M$47.64M$24.65M$39.71M$17.78M$9.88M$12.29M$6.11M$9.41M
    Current assets$61.47M$40.52M$44.16M$21.33M$37.09M$15.34M$7.81M$11.42M$5.16M$8.59M
    Cash and equivalents$8.94M$18.92M$9.64M$4.63M$12.00M$12.64M$5.51M$9.38M$3.71M$7.52M
    Total liabilities$14.20M$10.72M$8.14M$7.26M$6.18M$5.61M$4.50M$3.52M$3.38M$5.37M
    Short-term debt$1.07M$542.00K$557.00K$419.00K$420.00K$400.00K$362.00KN/A$0$2.68M
    Shareholder equity$55.20M$36.09M$39.50M$17.39M$33.53M$12.16M$5.38M$8.76M$2.73M$4.04M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$33.57M$44.64M$56.47M$69.40M$78.47M$33.34M$38.67M$46.81M$50.48M$55.66M$42.03M$47.64M
    Total liabilities$11.82M$13.13M$12.85M$14.20M$14.36M$13.10M$10.33M$10.72M$9.13M$8.90M$6.94M$8.14M
    Cash and equivalents$19.25M$15.15M$11.36M$8.94M$63.40M$11.51M$12.38M$18.92M$15.82M$28.39M$9.39M$9.64M
    Shareholder equity$21.75M$31.51M$43.62M$55.20M$64.11M$20.24M$28.34M$36.09M$41.35M$46.76M$35.09M$39.50M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$35.10M-$21.87M-$16.38M-$15.54M-$13.21M-$9.08M-$9.81M-$7.61M-$8.13M-$7.50M
    Capital expenditures$1.66M$1.40M$381.00K$473.00K$344.00K$88.00K$284.00K$67.00K$258.00K$49.00K
    Free cash flow-$36.77M-$23.27M-$16.76M-$16.02M-$13.55M-$9.17M-$10.09M-$7.67M-$8.39M-$7.54M
    Investing cash flow-$30.56M$12.64M-$16.09M$8.44M-$22.46M-$187.00K-$387.00K-$44.00K-$318.00K$70.00K
    Financing cash flow$55.57M$18.45M$37.53M-$140.00K$35.03M$16.39M$6.33M$13.37M$4.63M$11.70M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Operating cash flow-$10.89M-$12.34M-$9.35M-$8.63M-$8.33M-$8.79M-$6.75M-$5.70M-$4.35M-$5.06M-$4.18M-$4.04M
    Capital expenditures$330.00K$194.00K$398.00K$329.00K$576.00K$359.00K$311.00K$421.00K$475.00K$195.00K$215.00K$96.00K
    Free cash flow-$11.22M-$12.53M-$9.74M-$8.96M-$8.91M-$9.15M-$7.06M-$6.12M-$4.83M-$5.26M-$4.39M-$4.14M
    Last 12 quarters

    Frequently Asked Questions About NSPR

    What is InspireMD's annual revenue?

    InspireMD reported revenue of $8.98M for the fiscal year ended Dec 31, 2025.

    How fast is InspireMD's revenue growing?

    Revenue was up 28.1% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 20.2%.

    Is InspireMD profitable?

    No. InspireMD reported net income of -$48.79M for the fiscal year ended Dec 31, 2025, with a net margin of -543.3%.

    How much free cash flow does NSPR generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$35.10M minus capital expenditures of $1.66M produced free cash flow of -$36.77M.

    How much debt does InspireMD have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $1.07M and cash and equivalents of $8.94M.